Objective To evaluate trials of drugs that target amyloid to determine whether reductions in
amyloid levels are likely to improve cognition. Design Instrumental variable meta-analysis. …

Our nation is becoming increasingly diverse; however, few autopsy studies examine multiple
ethnoracial groups, especially Hispanics. We examined differences in neuropathological …

Importance Patients with a history of cancer, even nonfatal cancers, have lower subsequent
Alzheimer disease incidence. An inverse biological link between carcinogenesis and …

Background The relationship between education and late-life cognitive decline is controversial.
Selective survival between early life, when education is typically completed, and late life, …

The genetic make-up of an individual contributes to the susceptibility and response to viral
infection. Although environmental, clinical and social factors have a role in the chance of …

Background Alpha-1 antitrypsin deficiency (AATD) is an autosomal co-dominant condition
that predisposes to emphysema, cirrhosis, panniculitis, and vasculitis. Underrecognition has …

Genome-wide association studies (GWAS) have identified a number of risk loci for cutaneous
melanoma. Cutaneous melanoma shares overlapping genetic risk (genetic correlation) …

Objective To test the hypothesis that incipient Alzheimer disease (AD) may adversely affect
hearing and that hearing loss may adversely affect cognition, we evaluated whether genetic …

Polygenic risk scores (PRSs) are now showing promising predictive performance on a wide
variety of complex traits and diseases, but there exists a substantial performance gap across …

Weight loss or lower body mass index (BMI) could be an early symptom of Alzheimer disease
(AD), but when this begins to emerge is difficult to estimate with traditional observational …